Strasbourg, France

Marie-Christine Galas-Rodriguez, Legal Representative


Average Co-Inventor Count = 7.6

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Marie-Christine Galas-Rodriguez: Innovator in Carbamate Compounds

Introduction

Marie-Christine Galas-Rodriguez is a distinguished inventor and legal representative based in Strasbourg, France. She has made significant contributions to the field of chemistry, particularly in the development of carbamate compounds. With a total of three patents to her name, her work has implications for various applications in the pharmaceutical industry.

Latest Patents

Among her latest patents is the invention titled "Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas." This patent discloses a novel carbamate compound that has potential applications in drug formulation. Another notable patent is "Cyclic urea compounds and preparation thereof," which outlines a method for preparing cyclic urea compounds from activated carbamic acid derivatives. This method includes a cyclization step that involves a reaction between the amine function and the carbamic acid function of the derivatives.

Career Highlights

Marie-Christine has worked with several companies throughout her career, including Immupharma France SA and Neomps. Her expertise in legal representation and innovation has allowed her to navigate complex patent landscapes effectively.

Collaborations

She has collaborated with notable professionals in her field, including Gilles Guichard and Pierre Rodriguez, who also serve as legal representatives. Their combined expertise enhances the quality and impact of their work in the industry.

Conclusion

Marie-Christine Galas-Rodriguez stands out as a prominent figure in the realm of carbamate compound innovation. Her patents and collaborations reflect her commitment to advancing chemical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…